. 2016 Dec 2;34(1):207–220. doi: 10.1007/s12325-016-0443-1

Table 2.

Base case results: costs and cost-effectiveness of ISAV vs. VORI

Parameter	ISAV	VORI
Total cost per patient	$44,748.38	$52,166.16
Total drug cost	$3571.85	$3869.99
AE cost	$317.42	$576.74
Initial hospitalization cost	$37,678.04	$43,474.66
Hospital readmission cost	$3181.07	$4244.77
Incremental cost per death avoided	ISAV is dominant over VORI^a
Incremental cost per additional clinical responder	ISAV is dominant over VORI^a

ISAV isavuconazole, VORI voriconazole, AE adverse event

^a“Dominant” indicates greater health benefits (survival, clinical response) and lower cost